$2.00
0.052.83%
After Hours: 9:27 AM EDT
15 minutes delayed
Comments
Loading...
Mersana Therapeutics (MRSN) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestMersana Therapeutics (NASDAQ:MRSN) Stock Quotes, Forecast and News Summary
Mersana Therapeutics Stock (NASDAQ: MRSN) stock price, news, charts, stock research, profile.
| Open | $1.95 |
| Close | - |
| Volume / Avg. | 395.22K / 1.26M |
| Day Range | $1.86 - $1.97 |
| 52 Wk Range | 1.07 - 6.28 |
| Market Cap | $231.24M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 54 |
| Short Interest | 11.02% |
| Days to Cover | 10.84 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Mersana Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company using its differentiated and ...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Mersana Therapeutics (MRSN) stock?
You can purchase shares of Mersana Therapeutics (NASDAQ:MRSN) through any online brokerage.
Who are Mersana Therapeutics (MRSN) competitors?
Other companies in Mersana Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Cabaletta Bio (NASDAQ:CABA), Adaptimmune Therapeutics (NASDAQ:ADAP), Kyverna Therapeutics (NASDAQ:KYTX) and TScan Therapeutics (NASDAQ:TCRX).
What is the forecast, or price target, for Mersana Therapeutics (MRSN) stock?
Mersana Therapeutics has a consensus price target of $6.38.
What is the current price for Mersana Therapeutics (MRSN)?
The stock price for Mersana Therapeutics (NASDAQ: MRSN) is $2 last updated September 24, 2024 at 9:27 AM EDT.
Does Mersana Therapeutics (MRSN) pay a dividend?
There are no upcoming dividends for Mersana Therapeutics.
When is Mersana Therapeutics (NASDAQ:MRSN) reporting earnings?
Mersana Therapeutics’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
Is Mersana Therapeutics (MRSN) going to split?
There is no upcoming split for Mersana Therapeutics.
What sector and industry does Mersana Therapeutics (MRSN) operate in?
Mersana Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.